A history of antimicrobial drugs in animals: Evolution and revolution

Abstract

The evolutionary process of antimicrobial drug (AMD) uses in animals over a mere eight decades (1940–2020) has led to a revolutionary outcome, and both evolution and revolution are ongoing, with reports on a range of uses, misuses and abuses escalating logarithmically. As well as veterinary therapeutic perspectives (efficacy, safety, host toxicity, residues, selection of drug, determination of dose and measurement of outcome in treating animal diseases), there are also broader, nontherapeutic uses, some of which have been abandoned, whilst others hopefully will soon be discontinued, at least in more developed countries. Although AMD uses for treatment of animal diseases will continue, it must: (a) be sustainable within the One Health paradigm; and (b) devolve into more prudent, rationally based therapeutic uses. As this review on AMDs is published in a Journal of Pharmacology and Therapeutics, its scope has been made broader than most recent reviews in this field. Many reviews have focused on negative aspects of AMD actions and uses, especially on the question of antimicrobial resistance. This review recognizes these concerns but also emphasizes the many positive aspects deriving from the use of AMDs, including the major research‐based advances underlying both the prudent and rational use of AMDs. It is structured in seven sections: (1) Introduction; (2) Sulfonamide history; (3) Nontherapeutic and empirical uses of AMDs (roles of agronomists and veterinarians); (4) Rational uses of AMDs (roles of pharmacologists, clinicians, industry and regulatory controls); (5) Prudent use (residue monitoring, antimicrobial resistance); (6) International and inter‐disciplinary actions; and (7) Conclusions.

A Cross-Sectional Study of Antimicrobial Usage on Commercial Broiler and Layer Chicken Farms in Bangladesh

“…Doxycycline was also more commonly administered by less experienced broiler farmers and was often administered in combination with other antimicrobials, including colistin. The frequent use of colistin may reflect the fact that they are considered as an "essential" antimicrobial in the poultry industry and have been used there for a long time (52).…”

An introduction to the JVPT special issue on antimicrobial drugs

“…Research in prospective PK/PD relations (i.e., prospective clinical trials) is needed to enable evidence‐based dosing protocols in a variety of clinical situations. These points are discussed by Lees et al (2020).…”

First Insight into the Diversity and Antibacterial Potential of Psychrophilic and Psychotrophic Microbial Communities of Abandoned Amber Quarry

“…Antibiotic therapy is the most significant scientific achievement of the twentieth century in terms of its impact on human morbidity and mortality, but today, there are some problems that limit the use of antibiotics. The emergence of antibiotic-resistant pathogens is the main problem, while the high costs and risks associated with the development of new products lead to a shortage of new families of antibiotics that could compensate for resistance to existing ones [ 1 , 2 ]. Administration of broad-spectrum antibiotics can lead to collateral damage to the commensal microbiota, which plays an essential role in the health of the host and the growth in the number of atopic and autoimmune diseases [ 3 , 4 , 5 ].…”